Method Developed Monitors Adjuvant Levels in a Vaccine and Satisfies FDA Requirements Analytical method for vaccine product
Method Developed Monitors Adjuvant Levels in a Vaccine and Satisfies FDA Requirements Analytical method for vaccine product
1 PagesSpanos Method Developed Monitors Adjuvant Levels in a Vaccine and Satisfies FDA Requirements Challenge AAIPharma Services was asked to develop a method to monitor levels of an adjuvant in a vaccine product. The adjuvant component was a high molecular weight polymeric compound with no UV chromophore. The polymer contained both strongly hydropho- bic and strongly hydrophilic groups and was present in very low levels in the vaccine ma- trix.
